Cargando…
Maximum Tolerated Dose Evaluation of the AMPA Modulator Org 26576 in Healthy Volunteers and Depressed Patients: A Summary and Method Analysis of Bridging Research in Support of Phase II Dose Selection
BACKGROUND: A key challenge to dose selection in early central nervous system (CNS) clinical drug development is that patient tolerability profiles often differ from those of healthy volunteers (HVs), yet HVs are the modal population for determining doses to be investigated in phase II trials. Witho...
Autores principales: | Nations, Kari R., Bursi, Roberta, Dogterom, Peter, Ereshefsky, Larry, Gertsik, Lev, Mant, Tim, Schipper, Jacques |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3585695/ https://www.ncbi.nlm.nih.gov/pubmed/22852579 http://dx.doi.org/10.2165/11634360-000000000-00000 |
Ejemplares similares
-
Small RNA sequencing reveals a novel tsRNA-26576 mediating tumorigenesis of breast cancer
por: Zhou, Jun, et al.
Publicado: (2019) -
Pharmacokinetics of ASP4345 from Single Ascending-Dose and Multiple Ascending-Dose Phase I Studies
por: Desai, Amit, et al.
Publicado: (2020) -
Maximum Doses of Medicine
por: Kinglake,
Publicado: (1822) -
Biological effects of sub-lethal doses of glyphosate and AMPA on cardiac myoblasts
por: Arrigo, Elisa, et al.
Publicado: (2023) -
Radiation, doses, effects, risks
por: Union Nations Environment Programme. Nairobi, Kenya.
Publicado: (1985)